companies / infinanthealth-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-17 json
| total_raised | 39,247,55239.2M | D |
|---|---|---|
| founded | null | |
| hq | Sacramento, California | |
| industry | unknown | |
| stage | null |
Infinant Health develops B. infantis probiotic strains that pair with breast milk to build a healthy infant gut microbiome. Its lead product INF108 targets premature infants and the neonatal clinicians caring for them, aiming to prevent necrotizing enterocolitis. Its H5-positive strains digest human milk oligosaccharides far better than rivals.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-06-08 | Funding round | 39,247,55239.2M | null | D |
| person | role | src |
|---|---|---|
| Amanda Birdsey-Benson | director | D |
| Katharine Knobil | director | D |
| Laura Stoppel | director | D |
| Michael Johnson | director | D |
| Michael Johnson | executive | D |
| Mike Liang | director | D |
| Patrick Enright | director | D |
bootstrap 4.6.0, cloudflare, cloudflare bot management, font awesome, google tag manager, headroom.js, hsts, http/3, hubspot cms hub, jquery 3.6.0, jquery cdn, jsdelivr
| fact | status | src |
|---|---|---|
| Funding round, $39.2M | sourced | D |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-28latest_round: Funding round, $39.2M, 2026-06-08 → Funding round, $39.2M, 2026-06-08, D 2026-09-25 | latest_round | Funding round, $39.2M, 2026-06-08 → Funding round, $39.2M, 2026-06-08 | D 2026-09-25 |
| 2026-09-28total_raised: 39200000 → 39247552, D 2026-09-25 | total_raised | 39200000 → 39247552 | D 2026-09-25 |
| 2026-09-25latest_round: seed, $39.2M, 2026-06-08 → Funding round, $39.2M, 2026-06-08, D |
| Roger Wyse |
| director |
| D |
| latest_round |
| seed, $39.2M, 2026-06-08 → Funding round, $39.2M, 2026-06-08 |
| D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes